Jump to Content Jump to Main Navigation
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues
Submit now Author guidelines Reasons to publish Ethical policy Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues
Submit now Author guidelines Reasons to publish Ethical policy Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help

Volume 24 (2017): Issue 8 (Aug 2017)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

  • Sign up for new article alerts
  • Sign up for eTOC alerts
  • Get Accepted Manuscript Alerts
  • Review
    • Rationale for the development of alternative forms of androgen deprivation therapy
    • Estradiol for the mitigation of adverse effects of androgen deprivation therapy
  • Research
    • Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease
    • Testicular vs adrenal sources of hydroxy-androgens in prostate cancer
    • Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms
    • STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
    • A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
    • Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas
  • Research Letter
    • SDHB mutation carriers with malignant pheochromocytoma respond better to CVD
    • KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors
    • The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations
  • Letter to the Editor
    • A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery
  • Save
  • Email this content

    Share Link


    Copy this link, or click below to email it to a friend
    Email this content
    or copy the link directly:
    The link was not copied. Your current browser may not support copying via this button.
    Link copied successfully

  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821
  • Accessibility
  • Sales & advertising
  • Publishing alliances
  • Privacy & cookies
  • Terms and conditions
  • Permissions
  • Help

© 2022 Bioscientifica Ltd

Follow us on: Share Share

Print ISSN: 1351-0088; Online ISSN: 1479-6821    Powered by:

PubFactory
  • [44.192.65.228]
  • 44.192.65.228
Close
Edit

Character limit 500/500

@!

Character limit 500/500